concept

TAU PATHOLOGY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TAU PATHOLOGY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1229Connections

4Hypotheses

13Analyses

50Outgoing

50Incoming

0Experiments

20Debates

Summary

TAU PATHOLOGY is a concept in neurodegeneration research. Key relationships include: activates, biomarker for, therapeutic target. Associated with ALS, Aging, Als. Connected to 600 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	TAU PATHOLOGY
Key Genes/Proteins	ABCA1, ABI3, ACE, ADAM17, ADORA1, AGING
Related Diseases	aging, Aging, Als, ALS, Alzheimer
Related Pathways	Akt, Alpha-Synuclein

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Corticobasal Syndrome Tau Pathology

mechanism · 1913 words

→

Pathway Diagram

graph TD
    TAU_PATHOLOGY["TAU PATHOLOGY"]
    TAU_PATHOLOGY -->|"activates"| neurodegeneration["neurodegeneration"]
    TAU_PATHOLOGY -->|"causes"| synapse_loss["synapse loss"]
    TAU_PATHOLOGY -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
    TAU_PATHOLOGY -->|"activates"| inflammatory_responses["inflammatory responses"]
    TAU_PATHOLOGY -->|"activates"| neuroinflammation["neuroinflammation"]
    TAU_PATHOLOGY -.protects against.-> Alzheimer["Alzheimer"]
    autophagy_dysfunction["autophagy dysfunction"] -->|"activates"| TAU_PATHOLOGY
    necroptosis["necroptosis"] -->|"activates"| TAU_PATHOLOGY
    MHC_I["MHC-I"] -->|"activates"| TAU_PATHOLOGY
    APOE["APOE"] -->|"regulates"| TAU_PATHOLOGY
    ApoE4["ApoE4"] -->|"contributes to"| TAU_PATHOLOGY
    TREM2["TREM2"] -->|"regulates"| TAU_PATHOLOGY
    APOE3["APOE3"] -->|"regulates"| TAU_PATHOLOGY

Outgoing (660)

Target	Relation	Type	Str
tau pathology	encodes	protein	0.00
Alzheimer	associated_with	disease	1.00
Aging	associated_with	disease	1.00
Alzheimer	regulates	disease	1.00
Als	associated_with	disease	1.00
Neurodegeneration	associated_with	disease	1.00
Alzheimer	activates	disease	1.00
Alzheimer	biomarker_for	disease	1.00
ALZHEIMER'S DISEASE	therapeutic_target	gene	1.00
neurodegeneration	activates	process	1.00
Alzheimer	therapeutic_target	disease	1.00
Neurodegeneration	activates	disease	1.00
Als	biomarker_for	disease	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
MICROGLIA	activates	gene	1.00
ALZHEIMER'S DISEASE	associated_with	gene	1.00
Neurodegeneration	inhibits	disease	0.95
Alzheimer	protects_against	disease	0.95
Alzheimer'S Disease	biomarker_for	disease	0.95
Als	activates	disease	0.95
Neuroinflammation	regulates	disease	0.95
Inflammation	regulates	disease	0.95
Neurodegeneration	regulates	disease	0.95
Aging	activates	disease	0.95
Aging	therapeutic_target	disease	0.95
Alzheimer's Disease	associated_with	disease	0.95
Als	therapeutic_target	disease	0.95
Alzheimer'S	biomarker_for	disease	0.92
Behavior Variant Frontotemporal Dementia	involved_in	disease	0.92
Neuronal And Synaptic Loss	causes	phenotype	0.90
Schaffer collaterals	spreads_along	pathway	0.90
Necroptosis	associated_with	process	0.90
SST interneuron dysfunction	causes	mechanism	0.90
A1R	upregulates	protein	0.90
Alzheimer Disease	involved_in	disease	0.90
mitochondrial dysfunction	causes	process	0.90
Cognitive Decline	causes	phenotype	0.90
Neurodegeneration	causes	process	0.90
Alzheimer's Disease	drives	disease	0.90
DRP1	activates	protein	0.90
ALZHEIMER'S DISEASE	biomarker_for	gene	0.90
GFAP	biomarker_for	gene	0.90
Dementia	biomarker_for	disease	0.85
Neuroinflammation	activates	disease	0.85
Inflammation	associated_with	disease	0.85
Tauopathy	therapeutic_target	disease	0.85
cortical gray matter connectivity	mediates	phenotype	0.85
Inflammation	therapeutic_target	disease	0.85
Alzheimer	inhibits	disease	0.85
Inflammation	associated_with	process	0.85

Incoming (569)

Source	Relation	Type	Str
TAU PATHOLOGY	encodes	gene	0.00
TAU	activates	gene	1.00
NEURODEGENERATION	associated_with	gene	1.00
TAU	inhibits	gene	1.00
ALZHEIMER	activates	gene	1.00
TAU	associated_with	gene	1.00
ALZHEIMER	associated_with	gene	1.00
ALZHEIMER	therapeutic_target	gene	1.00
AMYLOID	associated_with	gene	1.00
AMYLOID	activates	gene	1.00
TAU	regulates	gene	1.00
Phosphorylated Tau 217	biomarker_for	biomarker	0.96
Lxr Agonist	suppresses	drug	0.95
mAb2A7	associated_with	drug	0.95
APOE4	associated_with	protein	0.95
Electroacupuncture	suppresses	drug	0.95
Plasma Ev Tau 3R/4R Ratio	biomarker_for	biomarker	0.94
Tau PET	biomarker_for	biomarker	0.93
P-Tau217	biomarker_for	biomarker	0.93
PSEN1	causes	gene	0.92
Neuroinflammation	involved_in	process	0.92
Tau Positron Emission Tomography	biomarker_for	biomarker	0.91
37415197	showed in	paper	0.90
autosomal dominant Alzheimer's Disease	causes	disease	0.90
34326423	is associated with	paper	0.90
Proteasomal Degradation	regulates	pathway	0.90
RING-Bait	associated_with	drug	0.90
34326423	is associated with	paper	0.90
proteasomal degradation	involved_in	process	0.90
TREM2 agonist	prevents	drug	0.90
TREM2 agonist antibodies	prevents	drug	0.90
36878332	does not associate with	paper	0.90
LDLR	inhibits	gene	0.90
BAG3	protects_against	protein	0.90
Dazucorilant	treats	drug	0.90
40264187	reduced	paper	0.90
Mab2A7	associated_with	drug	0.90
Intermediate Filaments	interacts_with	protein	0.90
ABCA1	suppresses	gene	0.90
Apoe4	associated_with	protein	0.90
29895964	correlates better with	paper	0.90
APOE-R136S	protects_against	protein	0.90
APOE4	upregulates	gene	0.90
APOE	mediates	gene	0.90
36153607	progresses preferentially between	paper	0.90
31285742	appears in	paper	0.90
APOE4	promotes	gene	0.90
Oligodendrocytes	interacts_with	cell_type	0.90
Aβ accumulation	causes	biomarker	0.90
Necroptosis	correlates_with	process	0.90

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
sex-divergent microglial activation states and X-linked immu	0.626	neurodegeneration	Sex-Specific Microglial States in Amyloi
Cell-state stratification is required to resolve Sex-Specifi	0.612	neurodegeneration	Sex-Specific Microglial States in Amyloi
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Sex-Specific Microglial States in Amyloi
CSF p-tau217 Normalization Reflects Amyloid-Driven Tau Patho	0.586	neurodegeneration	-

Mentioning Analyses (13)

Scientific analyses that reference this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (20)

Multi-agent debates referencing this entity

Related Research

Hypotheses and analyses mentioning TAU PATHOLOGY in their description or question text

No additional research found

TAU PATHOLOGY

Understanding Entity Pages

Summary

Wiki Pages (1)

Corticobasal Syndrome Tau Pathology

Pathway Diagram

Outgoing (660)

Incoming (569)

Targeting Hypotheses (4)

Mentioning Analyses (13)

Spatially Resolved Oligodendrocyte-Astrocyte Communication Networks Disrupted in

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

Multi-modal Biomarker Panel Design for Early AD Detection

Spatial Transcriptomics Analysis of Alzheimer's Disease Brain Regions

Why have numerous phase 3 clinical trials failed despite advances in understandi

Does tau aggregation specifically cause PS externalization in vesicles independe

Does tau aggregation specifically cause PS externalization in living cells versu

Can chaperone enhancement approaches overcome tau seed saturation effects in adv

Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression

Circuit-level neural dynamics in neurodegeneration

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Experiments (0)

Related Papers (0)

Debates (20)

What spatially resolved cell-cell communication networks between oligodendrocyte

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

Debate: Closed-loop tACS targeting EC-II somatostatin interneurons to restore de

Debate: Closed-loop transcranial focused ultrasound with real-time gamma feedbac

Hypothesis debate: Closed-loop transcranial alternating current stimulation to r

Related Research